Blog

  • Linklaters advises Ab&B Bio-Tech on its HKEX IPO

    Linklaters advises Ab&B Bio-Tech on its HKEX IPO

    Linklaters acted as the Hong Kong and US counsel for Ab&B Bio-Tech CO., LTD. JS (Ab&B Bio-Tech) on its global offering and listing of H shares on the Main Board of the Hong Kong Stock Exchange (HKEX) under Chapter 18A of the Hong Kong Listing Rules. The Hong Kong public offering was oversubscribed by over 4,000 times, making it one of the most popular new listings this year.

    Founded in 2015, Ab&B Bio-Tech is a China-based vaccine company dedicated to the research, development, manufacturing and commercialisation of innovative vaccines and traditional vaccines adopting new technical methods.

    The Linklaters team was led by partner and Head of Greater China ECM Christine Xu, capital markets partner Lipton Li and Special Senior Adviser and New Economy Team Leader (Greater China) Oliver Zhong, with support from corporate counsel Queenie Tong.

    Partner and Head of Greater China ECM Christine Xu commented:

    “Many congratulations to Ab&B Bio-Tech on this successful IPO! This transaction underscores the continued attractiveness of Hong Kong SAR as a listing destination and showcases Linklaters’ depth of expertise in advising fast-growing, innovative biotech companies on capital raising from public markets including achieving transformative milestones such as IPOs.”

    Linklaters’ highly experienced Greater China ECM team provides seamless legal support on pre-IPO investments, IPOs, post-listing compliance and post-IPO equity financing, including advising on the recent HKEX IPOs of CATL, Sanhua Intelligent and FWD Group, as well as share placings for Innovent Biologics, Keymed Biosciences, Minieye Technology and RoboSense.

    Continue Reading

  • Hong Kong author Louis Cha’s novels form the basis of China’s next AAA video game

    Hong Kong author Louis Cha’s novels form the basis of China’s next AAA video game

    CreateAI, formerly known as the autonomous vehicle firm TuSimple, aims to make Heroes of Jin Yong “one of the largest-scale triple-A, open-world role-playing games (RPGs)” in the market, president and CEO Lu Cheng told the South China Morning Post on the sidelines of the recent ChinaJoy 2025 trade show in Shanghai.

    “It is a huge software engineering project,” Lu said. He pointed out that the most difficult part of the development process was maintaining the high standards for both the game’s aesthetics and combat features, while handling a massive amount of digital resources.

    According to Lu, Heroes of Jin Yong will feature characters across a span of 300 years and more than 120 famous scenes from Cha’s 15 martial arts novels. Building on that foundation, the game will present an expansive 960-square-kilometre world teeming with diverse gameplay, side stories and an immersive wuxia experience.

    Continue Reading

  • Stock Futures Rise, Oil Falls on US-Russia Talks: Markets Wrap

    Stock Futures Rise, Oil Falls on US-Russia Talks: Markets Wrap

    (Bloomberg) — Equity-index futures for the US and Europe rose and oil declined on speculation a meeting between US and Russian leaders will increase the chances of ending the war in Ukraine and boost crude supply.

    Contracts for European shares gained 0.3%, while those for the S&P 500 Index climbed 0.2%. Oil fell 0.7%, the seventh decline in eight days, while gold also dropped as US President Donald Trump prepares to meet his Russian counterpart Vladimir Putin on Friday. Asian shares edged higher. There’s no cash trading in Treasuries in Asia due to a holiday in Japan.

    Asian lithium stocks rose after China’s Contemporary Amperex Technology Co. suspended production at a mine in Jiangxi province for at least three months, a move that may ease oversupply concerns.

    “The initial reaction from commodity markets — with both gold and oil prices sliding — underscores investors’ bullish bias for a breakthrough in this week’s US–Russia talks,” said Hebe Chen, an analyst at Vantage Markets in Sydney. “If such a deal is struck, it would not only sustain market optimism, but also mark this week as a historic turning point.”

    Financial markets are taking comfort from the prospect of ending the three-year old war in Ukraine after a flurry of discussions during the weekend with European nations seeking to talk to Trump ahead of his meeting in Alaska. Trump had threatened sanctions and also penalties on countries such as India that bought oil from Russia, prompting Putin to have phone calls with Narendra Modi and also other leaders.

    Diplomatic negotiations were in full swing during the weekend with National security advisers from Europe, Ukraine and the US meeting in the UK and making significant progress toward the ending of the fighting.

    The talks followed an earlier call between Ukraine President Volodymyr Zelenskiy and UK Prime Minister Keir Starmer, and a flurry of diplomacy involving Zelenskiy and other European leaders.

    Brent slipped back toward a $66 a barrel, after sliding 4.4% last week, while West Texas Intermediate was above $63. A peace deal with Ukraine could see an end to sanctions on supply from Russia, potentially exacerbating a glut forecast for later in the year.

    “Crafting an agreement is going to be extremely difficult,” said Robert Rennie, head of commodity and carbon research at Westpac Banking Corp. “Assuming we can eventually resolve this situation, the path for Brent is down below $65 with risks we may see sub-$60” late in the fourth quarter, he said.

    Investors are also awaiting key economic data this week and a deadline for the potential extension of US tariffs on Chinese exports. A key focus will be the US inflation report, expected to offer further insight into the Federal Reserve’s interest-rate path amid concern the economy is teetering on the edge of stagflation.

    Technology stocks will also be in focus after Nvidia Corp. and Advanced Micro Devices Inc. agreed to pay 15% of their revenues from chip sales to China to the US government as part of a deal with the Trump administration to secure export licenses.

    Chinese retail sales and industrial production data due later this week will be parsed after consumer and producer price data at the weekend indicated demand remains fragile. Traders are also waiting for confirmation that the Aug. 12 deadline for talks on US duties on Chinese imports will be extended.

    “The market has fully subscribed to the high probability of the tariff truce being rolled over for another 90 days,” said Chris Weston, head of research at Pepperstone Group in Melbourne.

    Some of the main moves in markets:

    Stocks

    S&P 500 futures rose 0.2% as of 10:58 a.m. Tokyo time Australia’s S&P/ASX 200 rose 0.3% Hong Kong’s Hang Seng was little changed The Shanghai Composite rose 0.2% Euro Stoxx 50 futures rose 0.2% Currencies

    The Bloomberg Dollar Spot Index was little changed The euro rose 0.1% to $1.1658 The Japanese yen was little changed at 147.62 per dollar The offshore yuan was little changed at 7.1872 per dollar Cryptocurrencies

    Bitcoin rose 1.2% to $119,805.08 Ether rose 2.1% to $4,306.47 Bonds

    Australia’s 10-year yield was little changed at 4.25% Commodities

    West Texas Intermediate crude fell 0.6% to $63.48 a barrel Spot gold fell 0.6% to $3,377.78 an ounce This story was produced with the assistance of Bloomberg Automation.

    –With assistance from Winnie Hsu.

    ©2025 Bloomberg L.P.

    Continue Reading

  • Wilczek’s Multiverse | Good vibrations: the music of black holes

    Wilczek’s Multiverse | Good vibrations: the music of black holes

    If mature black holes had personalities, they would be extremely introverted. They don’t let anything out – not light, not particles, and certainly not music.

    Hawking radiation is a fascinating exception to this rule, but for astrophysical black holes, it is a tiny effect.

    But before they settle down, during their brief but wild youth, newly formed black holes ring out a strange, pure music. It would be beautiful to experience, and soon we will be able to do it.

    When a new black hole is formed, say by collapse of a star or by fusion of other objects such as neutron stars or smaller black holes, the material that produced it gets swallowed up. Once that material passes beyond the newly formed event horizon, no trace of it remains perceptible.

    The baby black hole itself, as a distortion of space-time, quickly settles into a stable shape, sculpted by its own gravity. The same force that makes stars and planets very nearly into round balls – or, if they’re spinning, smooth ellipsoids – works even more powerfully to mould black holes.

    Precisely because they swallow all signs of their origin and squash any outer lumpiness, black holes reach a level of mathematical perfection that is unique among macroscopic objects. Given only a black hole’s mass and angular momentum, the equations of general relativity predict with utter precision the distortion of space-time it embodies.

    Continue Reading

  • Proximal Fibular Osteotomy in the Management of Medial Compartment Osteoarthritis of the Knee: A Prospective Study

    Proximal Fibular Osteotomy in the Management of Medial Compartment Osteoarthritis of the Knee: A Prospective Study


    Continue Reading

  • Calcium, protein most used among China centenarians, says new findings

    Calcium, protein most used among China centenarians, says new findings

    According to findings published in Geroscience, about one in 10 Chinese centenarians used dietary supplements.

    The prevalence was higher in men, with 12.3% of male centenarians taking health supplements, as compared to 10.7% among females.

    The study was conducted by researchers from the Academy for Healthy Longevity under the National University of Singapore and Department of Exercise Science and Recreation at CUNY Lehman College in the US.

    The research assessed data on dietary supplement usage based on a questionnaire given out during t he 2018 Chinese Longitudinal Healthy Longevity Survey (CLHLS).

    The survey is a large-scale examination of the health and longevity of adults over 65 years old in China.

    Of the 15,874 participants, there were 2,877 centenarians — including 2,169 females and 708 males — which were examined for this research. Their median age was 102.2 ± 2.6 years old for females and 101.8 ± 2.2 years old for males.

    Among them, 10.7% females (232) and 12.3 males (87) used supplements. Most consumed a single supplement (7.3–8.8%), followed by two supplements (1.7–2.0%). Less than 1% consumed three or more supplements.

    Calcium was the most consumed supplements, with the prevalence of use at 6.5% for female and 7.3% among male centenarians.

    Both female and male centenarians took calcium supplements for a median duration of five years, with 3.7% females and 3.8% males saying that they took it “often”.

    Another 0.9% females and 0.6% males said they took it “sometimes” and 1.8% females and 2.8% males said they “seldom” took calcium supplements.

    Protein was the next most consumed supplement, with 3.7% females and 5.8% males said they have used it. The median duration of usage was five years for females and four years for males, with 2.3% females and 4.1% men saying they took it “often”.

    Multivitamins were the third most used supplement among the centenarians, with 3% males and 2.8% females using multivitamins across a median period of five years.

    Reasons to be determined

    Reasons for calcium and protein supplementation among the centenarians were unclear, the researchers said, as the CLHLS survey did not collect information on this.

    Nonetheless, the researchers cited data from the US where older adults commonly take calcium supplements for bone health, which could possibly be a reason among the China centenarians.

    “Data from the United States indicate that older adults commonly take calcium supplements for “bone health” and multivitamins to “improve overall health”.

    “These two supplements were also among the most frequently used in this analysis, possibly due to similar motivations.

    “However, because the CLHLS did not collect information on participants’ reasons for supplement use, future research should incorporate questions about motivations and specific purposes for using dietary supplements,” said the researchers.

    Based on past reports, companies such as Haleon has reported a stronger demand for calcium supplements in China as compared to other regions. In particular, calcium absorption benefit claims have resonated strongly with China consumers.

    China’s homegrown supplement giant, BYHEALTH, on the other hand, has protein powder as its bestseller across the country. Especially since COVID-19, protein supplementation became popular in China for its purported immune health benefits.

    On the other hand, based on the survey findings, some centenarians only started taking dietary supplements after they turned 100 instead of throughout their older adult life.

    This could be due to advice from caregivers or indicate the centenarians’ evolving opinions on the benefits of taking supplements.

    “These data highlight that the participants did not necessarily consume dietary supplements throughout their older adult life.

    “Accordingly, this raises important questions about the motivations behind starting supplement use at such an advanced age; whether due to a recent health diagnosis, advice from caregivers or healthcare providers, changes in perceived nutritional needs and/or evolving opinions about the risks and benefits of dietary supplementation,” said the researchers.

    DHA the least used

    According to the survey findings, DHA was the least used supplement among the centenarians.

    Only 0.4% out of the 232 female and 0.7% out of the 87 male centenarians had used DHA before.

    In addition, the median years of taking DHA was longer at 7.5 years for men and two years for women.

    Iron, zinc, vitamin A, D were the other supplements included in the survey.

    Vitamin A, D had a greater prevalence of use as compared to iron and zinc.

    For vitamin A and D for instance, the rate of use was 1.9% for females and 2.1% for males — with a median duration of use at five years and six years respectively.

    For both iron and zinc, the prevalence of use was 1.2% and median duration of three years for females.

    Amongst men, the prevalence of iron supplementation was 1.4% and 1.3% for zinc, both had a median duration of use of 10 years.

    Clearer definitions for frequency of use needed

    On the other hand, the researchers acknowledged that clearer definitions for frequency of use would be needed.

    The survey had categorized the frequency of supplements use as “seldom”, “sometimes”, or “often” without clear definitions, leaving it up to individuals’ interpretations.

    “These categories might have different interpretations between individuals, and therefore these responses could be expanded to more specific information such as “taken multiple times per day”, “taken once per day”, “taken 1–7 days per week”.

    “Such data would provide more specific insights into the frequency of use. The survey did not include questions about lifetime supplement use, limiting the ability to draw conclusions about long-term effects,” they said.

    In addition, due to the study’s descriptive analysis, the findings cannot be used to determine the direct impact of dietary supplementation on longevity.

    “It is unclear whether supplement use contributed in any meaningful way to the participants’ extended lifespan, or whether it was simply a coincidental behavior adopted in life.

    “Individuals who are exceptionally long-lived may be more inclined to adopt health-promoting behaviors, such as taking supplements, rather than such behaviors being a driver of their longevity.

    “The impact of dietary supplements on health outcomes and lifespan in centenarian populations should be further explored in longitudinal studies,” said the researchers.

    Source: Nutrients, 2025 ; doi: s11357-025-01782-8, “Dietary supplement use in longevity: evidence from 2,877 centenarians”, Authors: Grgic, J. et al.

    Continue Reading

  • CATL says it has suspended mining operations at Yichun project

    CATL says it has suspended mining operations at Yichun project

    BEIJING (Reuters) -Chinese electric vehicle battery manufacturing giant Contemporary Amperex Technology (CATL) said on Monday that it has suspended mining operations in the southern region of Yichun after a mining licence expired on August 9.

    “We are handling the application for renewing the mining license as soon as possible in accordance with relevant regulations,” the company said on an investors interactive platform without elaborating on the length of the production halt at the mine in Jiangxi province.

    CATL has suspended production at the Jianxiawo lithium mine for at least three months, Bloomberg News reported on Sunday, citing people familiar with the matter.

    “Once approved, we will resume production,” said CATL, adding that it will have little impact on the company’s overall operation.

    The most active lithium carbonate futures on the Guangzhou Futures Exchange surged by 8% to hit the price limit up on Monday.

    (Reporting by Amy Lv and Lewis Jackson; Editing by Kim Coghill)

    Continue Reading

  • ‘I’ve Started to Notice Small Changes Already’

    ‘I’ve Started to Notice Small Changes Already’

    NEED TO KNOW

    • Erin Kelly, a 29-year-old single mom from Australia, has been diagnosed with a rare form of Alzheimer’s disease

    • Kelly says she’s already experiencing symptoms after multiple members of her family, including her mother, died early from the disease

    • Kelly doesn’t know when to tell her 8-year-old daughter Evie about her diagnosis

    A young mother in Australia is speaking out about receiving a heartbreaking health diagnosis at age 29.

    Erin Kelly, from Eagleby, Queensland, learned she had early-onset Alzheimer’s disease in June of this year, after tests confirmed in May 2024 that she’d inherited a rare genetic mutation called PSEN1 from her mother, Robyne, per 7News.

    Kelly — who is a single mom to 8-year-old daughter, Evie — told the outlet of the diagnosis, “My [mom] died of Alzheimer’s when she was 50,” adding, “The disease took my grandfather at 45, and my aunt when she was the same age. I just didn’t think it would come for me so soon.”

    Getty

    A doctor consoling a woman (stock image).

    Per the Mayo Clinic, “Young-onset Alzheimer’s disease is an uncommon form of dementia that affects people younger than age 65. The condition also is called early-onset Alzheimer’s disease.”

    “Most people with Alzheimer’s are age 65 and older. About 1 in 9 people age 65 and older in the United States has Alzheimer’s disease. About 110 of every 100,000 adults between ages 30 and 64 have young-onset Alzheimer’s,” the site adds.

    Kelly’s father had revealed she and her siblings had a 50/50 chance of getting Alzheimer’s disease in January 2020, per news.com.au.

    “Originally I think I was in a little bit of denial, and I originally said I didn’t want to know,” she said, according to the outlet.

    “I sort of stuck my head in the sand and just pretended it wasn’t happening for probably the first three years, until I decided that I needed to do something about it,” Kelly added.

    Getty A doctor (stock image).

    Getty

    A doctor (stock image).

    Scans revealed the first signs of damage to Kelly’s neurons, which are cells in the brain that send messages all over the body, in June, 7News noted.

    “I’ve started to notice small changes already,” Kelly told the outlet of already noticing symptoms. “Forgetting words and mixing words together.”

    “I’ll be thinking of something, and I’ll just mush the words together,” she added. “It’s things I didn’t do previously.”

    Kelly said of her daughter Evie, “We’re not exactly sure how or what to tell her yet. She’s still so young.”

    https://people-app.onelink.me/HNIa/kz7l4cuf

    “She will get some information, but we want to protect her for as long as we can,” she continued, per the outlet. “The goal is to see her finish school, get married. I want to make sure she’s an adult before I die.”

    Kelly’s stepsister, Jessica Simpson, started a GoFundMe page to help raise money for treatment, claiming that Kelly had been “told she’s too young to qualify for clinical trials in Australia.”

    “There is a treatment called Leqembi. It’s not a cure, but it could slow the progression and give Erin more time — to keep working, keep functioning, and most importantly, keep being Evie’s [mom] for as long as she can,” Simpson wrote on the page. “But this medication isn’t available through the public system [in Australia] and is incredibly expensive.”

    Never miss a story — sign up for PEOPLE’s free daily newsletter to stay up-to-date on the best of what PEOPLE has to offer​​, from celebrity news to compelling human interest stories.

    According to the Alzheimer’s Association, Lecanemab (Leqembi) “has received traditional approval from the U.S. Food and Drug Administration (FDA) to treat early Alzheimer’s disease, including people living with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease who have confirmation of elevated beta-amyloid in the brain.”

    “Leqembi lowers beta-amyloid in the brain and reduces cognitive and functional decline in people living with early Alzheimer’s,” the association states.

    Simpson said on the GoFundMe page of her stepsister’s diagnosis, “It’s rare. It’s terminal. And it’s already starting to affect her life.”

    “Most people don’t associate Alzheimer’s with someone so young — someone still packing school lunches, doing bedtime stories, and showing up every day for her child. But this is Erin’s reality. And sadly, it’s progressing fast,” she added.

    Simpson insisted, “Erin isn’t asking for a miracle — she knows there’s no cure in time for her. She’s simply asking for more time. More ordinary days. More little moments. More memories Evie can carry with her when Erin no longer can.”

    The Mayo Clinic says it is rare for young-onset Alzheimer’s to be “caused by a specific error in a gene, called a genetic mutation,” which “can be passed from parent to child”: “Three different genes may have a mutation that causes young-onset Alzheimer’s disease. These genes are APP, PSEN1 or PSEN2.”

    PSEN1 is the genetic mutation that Kelly inherited.

    “A person who inherits at least one copy of a mutated gene will likely develop Alzheimer’s disease before age 65,” the Mayo Clinic adds.

    “About 11% of people with young-onset Alzheimer’s carry a genetic mutation that causes disease. But among all people with Alzheimer’s disease, fewer than 1% carry one of these causal genes,” the site states.

    PEOPLE has reached out to Simpson for an update on Kelly’s diagnosis.

    Read the original article on People

    Continue Reading

  • Chipping away at semiconductor revenues

    Chipping away at semiconductor revenues

    U.S. President Donald Trump (L) listens as Nvidia CEO Jensen Huang speaks in the Cross Hall of the White House during an event on “Investing in America” on April 30, 2025 in Washington, DC.

    Andrew Harnik | Getty Images

    U.S. markets continue to ride the artificial intelligence wave, with the tech-heavy Nasdaq Composite closing at fresh all-time highs Friday and other major indexes also rising.  

    The seismic shifts from the AI wave can be felt everywhere — from fueling the rise of new billionaires at a record pace to drastically changing the cybersecurity and defense landscape and how governments are looking to gain from the boom.  

    No wonder semiconductors powering AI have become an important piece on the trade chess board. In fact, the U.S. government is trying to profit from allowing chip companies access to the large Chinese market. On Wednesday, reportedly Nvidia CEO Jensen Huang met with U.S. President Donald Trump at the White House and agreed to give the federal government a 15% cut of its sales in China. Another chipmaker, AMD, agreed to the same deal. 

    Nvidia, meanwhile, has been fending off allegations from Chinese state media that its H20 AI chips pose a national security risk for China as it looks to resume sales to the country.

    While investors appear to be cheering on AI stocks — Nvidia gained over 1% Friday — they are also bracing for a data-heavy week ahead. The consumer price index, out Tuesday, will be particularly in focus as it could offer clarity on the Federal Reserve's rate path. 

    — Nur Hikmah Md Ali

    What you need to know today

    Nvidia refutes security risk allegations. The chip giant pushed back Sunday after an account affiliated with the Chinese state broadcaster CCTV said its chips were not safe and had a "remote shutdown" function.

    U.S. stocks post a winning week. On Friday, the Nasdaq Composite jumped 0.98% to a fresh record high. The S&P 500 also gained to close just a few points shy from a new record. The pan-European Stoxx 600 index gained 0.19%.

    Nvidia and AMD agree to pay 15% of China chip sales to the U.S. The chipmakers will receive export licenses in exchange, in an unprecedented arrangement with the White House, according to the Financial Times.

    Loud luxury makes a comeback. High-end brands are pivoting to visible opulence in a bid to woo shoppers as they grapple with multiple headwinds, including trade tariffs and soft consumer sentiment.

    [PRO] Data-heavy week for Wall Street. The latest consumer price index is set to release Tuesday, and the producer price index is due out Thursday. Investors also await other economic data such as retail sales, as they assess whether the Federal Reserve will cut rates in September.

    And finally...

    Kate Green | Getty Images Entertainment | Getty Images

    From lipsticks and Labubu dolls to concerts, the 'treatonomics' trend is booming in uncertain times

    "Treatonomics" — a consumer trend that covers spending on "everyday luxuries" to larger, life-affirming experiences — is booming as people look for a mood boost in times of economic uncertainty.

    The volatility we are experiencing is not likely to dissipate for the next five to eight years, retail analysis firm Kantar predicts.

    "This gives us a strong indication that treatonomics will persist for at least another three to five years," Kantar's Senior Director Meredith Smith said.

    — Holly Ellyatt


    Continue Reading

  • Giant planet found orbiting tiny star ‘should not exist’, astronomers say |

    Giant planet found orbiting tiny star ‘should not exist’, astronomers say |

    Astronomers have discovered a giant planet named TOI-6894b orbiting a very small red dwarf star that has only one-fifth the mass of the Sun. Despite the star’s small size and low brightness, TOI-6894b is larger than Saturn but has only half its mass. This surprising discovery challenges previous ideas that such tiny stars cannot form or hold large gas planets. According to a study published in Nature Astronomy and reported by Earth.com, large planets may be more common around small stars than scientists once believed, opening new possibilities for understanding how planets form.

    Huge planet discovered orbiting one of the smallest red dwarf stars: TOI-6894B

    TOI-6894b was found using data from the Transiting Exoplanet Survey Satellite (TESS). Its host star, TOI-6894, is a cool red dwarf, much smaller and dimmer than our Sun. Despite this, TOI-6894b has a radius larger than Saturn but with only half its mass. This makes the star the smallest known to have such a large gas giant orbiting it. This discovery challenges the assumption that small stars cannot form or hold giant planets.

    Challenging planet formation theories: How TOI-6894b formed around a tiny star

    Traditional planet formation theories, such as core accretion, suggest that low-mass stars have thin discs of gas and dust that are not enough to build large planets. Scientists believe TOI-6894b could have formed through a modified core accretion process or through gravitational instability, where parts of the disc collapse quickly under their own gravity. Neither explanation perfectly fits current data, highlighting the need for further research to understand how such a massive planet can form around a tiny star.

    James Webb Telescope to study TOI-6894b’s rare methane and ammonia atmosphere

    TOI-6894b orbits far enough from its star to have a relatively cool atmosphere, with an estimated temperature of 420 Kelvin (about 147 degrees Celsius). Its atmosphere is expected to be rich in methane, which is rare among exoplanets, and may contain ammonia as well. The James Webb Space Telescope (JWST) will observe this planet soon, providing valuable data to better understand its atmosphere and formation. This could offer important clues about planet formation in environments very different from our own solar system.

    Implications for astronomy and the Milky Way

    This discovery has big implications for astronomy. Since most stars in the Milky Way are small red dwarfs, finding a giant planet around one suggests that such planets may be more common than previously thought. The study involved researchers from the University of Warwick, University College London, and the University of Birmingham. TOI-6894b challenges existing models and will help scientists improve their understanding of planet formation and the diversity of planetary systems in our galaxy.Also read | Seven superclouds: Giant gas neighbors of our solar system discovered


    Continue Reading